Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

1.

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

Wilken R, Veena MS, Wang MB, Srivatsan ES.

Mol Cancer. 2011 Feb 7;10:12. doi: 10.1186/1476-4598-10-12. Review.

PMID:
21299897
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Curcumin and lung cancer-a review.

Mehta HJ, Patel V, Sadikot RT.

Target Oncol. 2014 May 21. [Epub ahead of print]

PMID:
24840628
[PubMed - as supplied by publisher]
3.

Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling.

Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB.

Int J Cancer. 2004 Sep 20;111(5):679-92. Erratum in: Int J Cancer. 2004 Dec 20;112(6):1086.

PMID:
15252836
[PubMed - indexed for MEDLINE]
4.

Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.

Wang D, Veena MS, Stevenson K, Tang C, Ho B, Suh JD, Duarte VM, Faull KF, Mehta K, Srivatsan ES, Wang MB.

Clin Cancer Res. 2008 Oct 1;14(19):6228-36. doi: 10.1158/1078-0432.CCR-07-5177.

PMID:
18829502
[PubMed - indexed for MEDLINE]
Free Article
5.

Anti-cancer effects of curcumin on head and neck cancers.

Gao W, Chan JY, Wei WI, Wong TS.

Anticancer Agents Med Chem. 2012 Nov;12(9):1110-6. Review.

PMID:
22583425
[PubMed - indexed for MEDLINE]
6.

Curcumin and cancer: an "old-age" disease with an "age-old" solution.

Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB.

Cancer Lett. 2008 Aug 18;267(1):133-64. doi: 10.1016/j.canlet.2008.03.025. Epub 2008 May 6. Review.

PMID:
18462866
[PubMed - indexed for MEDLINE]
7.

Curcumin suppresses growth of head and neck squamous cell carcinoma.

LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES, Wang MB.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6994-7002.

PMID:
16203793
[PubMed - indexed for MEDLINE]
Free Article
8.

Anticancer potential of curcumin: preclinical and clinical studies.

Aggarwal BB, Kumar A, Bharti AC.

Anticancer Res. 2003 Jan-Feb;23(1A):363-98. Review.

PMID:
12680238
[PubMed - indexed for MEDLINE]
9.
10.

Curcumin: the Indian solid gold.

Aggarwal BB, Sundaram C, Malani N, Ichikawa H.

Adv Exp Med Biol. 2007;595:1-75. Review.

PMID:
17569205
[PubMed - indexed for MEDLINE]
11.

Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.

Chan LP, Chou TH, Ding HY, Chen PR, Chiang FY, Kuo PL, Liang CH.

Biochim Biophys Acta. 2012 Jul;1820(7):1081-91. doi: 10.1016/j.bbagen.2012.04.013. Epub 2012 Apr 24.

PMID:
22554915
[PubMed - indexed for MEDLINE]
Free Article
12.
13.

Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.

Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE.

Clin Cancer Res. 2005 Oct 15;11(20):7490-8.

PMID:
16243823
[PubMed - indexed for MEDLINE]
Free Article
14.

Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers.

Herbst RS, Langer CJ.

Semin Oncol. 2002 Feb;29(1 Suppl 4):27-36. Review.

PMID:
11894011
[PubMed - indexed for MEDLINE]
15.

Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.

Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Deorukhkar A, Gelovani J, Guha S, Krishnan S, Aggarwal BB.

Int J Cancer. 2009 Nov 1;125(9):2187-97. doi: 10.1002/ijc.24593. Erratum in: Int J Cancer. 2010 Feb 1;126(3):799. Kuzhuvelil, Harikumar B [corrected to Harikumar, Kuzhuvelil B].

PMID:
19623659
[PubMed - indexed for MEDLINE]
16.

Curcumin inhibits carcinogen and nicotine-induced Mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma.

Clark CA, McEachern MD, Shah SH, Rong Y, Rong X, Smelley CL, Caldito GC, Abreo FW, Nathan CO.

Cancer Prev Res (Phila). 2010 Dec;3(12):1586-95. doi: 10.1158/1940-6207.CAPR-09-0244. Epub 2010 Sep 17.

PMID:
20851953
[PubMed - indexed for MEDLINE]
18.

Curcumin treatment suppresses IKK╬▓ kinase activity of salivary cells of patients with head and neck cancer: a pilot study.

Kim SG, Veena MS, Basak SK, Han E, Tajima T, Gjertson DW, Starr J, Eidelman O, Pollard HB, Srivastava M, Srivatsan ES, Wang MB.

Clin Cancer Res. 2011 Sep 15;17(18):5953-61. doi: 10.1158/1078-0432.CCR-11-1272. Epub 2011 Aug 5.

PMID:
21821700
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts.

Zhu S, Moore TW, Lin X, Morii N, Mancini A, Howard RB, Culver D, Arrendale RF, Reddy P, Evers TJ, Zhang H, Sica G, Chen ZG, Sun A, Fu H, Khuri FR, Shin DM, Snyder JP, Shoji M.

Integr Biol (Camb). 2012 Jun;4(6):633-40. doi: 10.1039/c2ib20007d. Epub 2012 Apr 25.

PMID:
22532032
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.

Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB.

Mol Pharmacol. 2006 Jan;69(1):195-206. Epub 2005 Oct 11.

PMID:
16219905
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk